Clinical Trial Update: Endostatin in Combination With Chemotherapy for Metastatic Nasopharyngeal Carcinoma [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial tests endostatin in combination with chemotherapy for metastatic nasopharyngeal carcinoma, sponsored by Zhejiang Cancer Hospital; the s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• Endostatin (endostatin)

Snippet

Sponsor: Zhejiang Cancer Hospital | Conditions: Effects of Chemotherapy, Stage IVC Nasopharyngeal Carcinoma | Phase 3 | Status: UNKNOWN